Ataxia telangiectasia mutated (ATM) kinase inhibitors (BioFocus/CHDI)

N/A

Report date: 2025/01/15 20:00:32
NME

Base Information

Drug NameAtaxia telangiectasia mutated (ATM) kinase inhibitors (BioFocus/CHDI)
Drug Alias NameCHDI-00491453CHDI-485194CHDI-00485194CHDI-484327
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine-protein kinase ATM inhibitors
TargetsSerine-protein kinase ATM
Therapy Area/IndicationsHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBioFocus DPI
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBioFocus DPIChdi Foundation Inc
Active IndicationsN/A
Inactive IndicationsHuntington Disease

Other Information

ATC CodeN/A
Related LinksN/A